Dendritic Cell-Derived IL-32α: A Novel Inhibitory Cytokine of NK Cell Function

J Immunol. 2017 Aug 15;199(4):1290-1300. doi: 10.4049/jimmunol.1601477. Epub 2017 Jul 12.

Abstract

Cytokines produced by dendritic cells (DCs) can largely determine the direction of immunity. Transcriptional analysis revealed that besides IL-15, IL-32 was the only other cytokine expressed by human Langerhans cells. IL-32 is a human cytokine that exists in four main isoforms. Currently, little is known about the regulation and function of the various IL-32 isoforms. In this study, we found that IL-15 is a potent inducer of IL-32α in DCs. Because IL-15 promotes NK cell activation, we investigated the interplay between IL-32 and IL-15 and their role in NK cell activity. We show that IL-32α acts on NK cells to inhibit IL-15-mediated STAT5 phosphorylation and to suppress their IL-15-induced effector molecule expression and cytolytic capacity. IL-32α also acted on DCs by downregulating IL-15-induced IL-18 production, an important cytokine in NK cell activity. Blocking IL-32α during DC:NK cell coculture enhanced NK cell effector molecule expression as well as their cytolytic capacity. Taken together, our findings suggest a feedback inhibition of IL-15-mediated NK cell activity by IL-32α.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Communication
  • Coculture Techniques
  • Cytotoxicity, Immunologic
  • Dendritic Cells / immunology*
  • Humans
  • Interleukin-15 / immunology
  • Interleukin-15 / metabolism
  • Interleukins / immunology*
  • Interleukins / metabolism
  • Interleukins / pharmacology
  • Killer Cells, Natural / immunology*
  • Killer Cells, Natural / physiology*
  • Langerhans Cells / immunology
  • Lymphocyte Activation
  • Signal Transduction
  • Skin / cytology
  • Skin / immunology

Substances

  • IL15 protein, human
  • IL32 protein, human
  • Interleukin-15
  • Interleukins